Volume 22 Issue 10
Oct.  2024
Turn off MathJax
Article Contents
Article Navigation >  Chinese Journal of General Practice  > 2024  >  22(10): 1640-1644
XU Boyang, YANG Wendi, LI Wei, JIA Zhichun, XU Wei, WANG Jiawan. Comparison and analysis of traditional Chinese medicine and Western medicine in the treatment of ulcerative colitis[J]. Chinese Journal of General Practice, 2024, 22(10): 1640-1644. doi: 10.16766/j.cnki.issn.1674-4152.003701
Citation: XU Boyang, YANG Wendi, LI Wei, JIA Zhichun, XU Wei, WANG Jiawan. Comparison and analysis of traditional Chinese medicine and Western medicine in the treatment of ulcerative colitis[J]. Chinese Journal of General Practice, 2024, 22(10): 1640-1644. doi: 10.16766/j.cnki.issn.1674-4152.003701
shu

Comparison and analysis of traditional Chinese medicine and Western medicine in the treatment of ulcerative colitis

doi: 10.16766/j.cnki.issn.1674-4152.003701
  • 1.

    Department of Integrative Medicine, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia 010017, China

Funds:

 2023SHZR1708

 202201067

  • Received Date: 2024-02-12
    Available Online: 2024-12-28
    Abstract
  • Ulcerative colitis (UC), as a common inflammatory bowel disease (IBD), has an etiology that is not yet fully understood. Many scholars believe that an imbalance between host genetic susceptibility and abnormal environmental factors disrupted relationship between host immunity and intestinal microbiota, promoting the development of intestinal inflammation in UC patients. In treatment, Western medicine typically uses aminosalicylates, steroids, immunomodulators, and biological agents. These medications primarily target inflammatory responses and immune regulation, significantly improving symptoms in a short time, especially in controlling acute attacks and severe UC. However, these medications generally come with varying degrees of side effects and may lead to patient dependency, increasing the risk of relapse after discontinuation. Traditional Chinese medicine (TCM) views UC as a disease caused by external pathogens, improper diet, and emotional disturbances, all occurring against a backdrop of inherent spleen and stomach weakness. In treatment, TCM has shown significant efficacy in managing mild cases of UC and during remission stages. TCM treatment not only focuses on the disease itself but also pays great attention to individual differences among patients. Through syndrome differentiation, personalized treatment plans are formulated for each patient. Additionally, TCM offers a variety of treatment methods, including oral decoctions, herbal enemas, suppository anal administrations, and acupuncture. These treatments help alleviate symptoms, improve intestinal function, enhance quality of life, have fewer side effects, and provide lasting efficacy. This article aims to compare and analyze the current status of TCM and Western medicine in treating UC from four aspects: TCM etiology and pathogenesis, TCM treatment, Western medicine pathogenesis, and Western medicine treatment. It also explores the feasibility of integrating TCM and Western medicine in treating UC, providing new insights and methods for the diagnosis and treatment of this disease.

     

    • FullText(HTML)
  • loading
    • References(43)
  • [1]
    张心愿, 梁樑, 丁荣琴, 等. 溃疡性结肠炎的中医治疗进展[J]. 河南外科学杂志, 2022, 28(4): 176-178.

    ZHANG X X, LIANG L, DING R Q, et al. Progress of traditional Chinese medicine treatment of ulcerative colitis[J]. Henan Journal of Surgery, 2022, 28(4): 176-178.
    [2]
    DU L, HA C. Epidemiology and pathogenesis of ulcerative colitis[J]. Gastroenterol Clin North Am, 2020, 49(4): 643-654. doi: 10.1016/j.gtc.2020.07.005
    [3]
    施俊峰, 张怡, 程敬, 等. 从"脾胃内伤, 百病由生"探讨溃疡性结肠炎病机观[J]. 辽宁中医杂志, 2022, 49(2): 48-50.

    SHI J F, ZHANG Y, CHENG J, et al. Discussion on the pathogenesis of ulcerative colitis from "internal injury of spleen and stomach, origin of all diseases"[J]. Liaoning Journal of Traditional Chinese Medicine, 2022, 49(2): 48-50.
    [4]
    韦鹏飞, 胡双元, 张怡, 等. 基于脾"苦欲补泻"理论从脾阴论治溃疡性结肠炎[J]. 北京中医药大学学报, 2022, 45(6): 641-644.

    WEI P F, HU S Y, ZHANG Y, et al. Treatment on ulcerative colitis from the spleen-yin based on the theory of spleen "like or dislike tonifying and purgative"[J]. Journal of Beijing University of Traditional Chinese Medicine, 2022, 45(6): 641-644.
    [5]
    童云, 刘亚军, 沈洪. 从痢后风角度探讨溃疡性结肠炎合并关节病变之辨治[J]. 江苏中医药, 2022, 54(5): 27-30.

    TONG Y, LIU Y J, SHEN H. Treatment of ulcerative colitis with joint disease from the perspective of dysentery and wind[J]. Jiangsu Journal of Traditional Chinese Medicine, 2022, 54(5): 27-30.
    [6]
    张国霞, 李宇飞, 王晓锋, 等. 李华山教授治疗溃疡性结肠炎的临证经验[J]. 中国医药导报, 2021, 18(20): 120-123.

    ZHANG G X, LIY F, WANG X F, et al. Clinical experience of Professor Li Huashan in the treatment of ulcerative colitis[J]. China Mediceal Herald, 2021, 18(20): 120-123.
    [7]
    易义成, 沙静涛. 沙静涛治疗溃疡性结肠炎经验[J]. 湖北中医杂志, 2020, 42(2): 19-22.

    YI Y C, SHA J T. Experience of Sha Jingtao in the treatment of ulcerative colitis[J]. Hubei Journal of Traditional Chinese Medicine, 2020, 42(2): 19-22.
    [8]
    谈望晶, 朱向东, 安耀荣, 等. 从情志致病探讨中医论治溃疡性结肠炎的疗效机制[J]. 辽宁中医杂志, 2019, 46(5): 964-966.

    TAN W J, ZHU X D, AN Y R, et al. Discussion on Therapeutic Mechanism of TCM on Ulcerative Colitis from Pathogenicity of Emotion[J]. Liaoning Journal of Traditional Chinese Medicine, 2019, 46(5): 964-966.
    [9]
    张晓明, 柳越冬, 都静, 等. 中医学理论指导下的溃疡性结肠炎病因病机研究进展[J]. 中华中医药学刊, 2023, 41(9): 46-52.

    ZHANG X M, LIU Y D, DU J, et al. Research Progress on Etiology and Pathogenesis of Ulcerative Colitis under Guidance of Traditional Chinese Medicine Theory[J]. Chinese Archives of Traditional Chinese Medicine, 2023, 41(9): 46-52.
    [10]
    李伟, 徐伟. 溃疡性结肠炎中医治疗进展[J]. 锦州医科大学学报, 2022, 43(2): 108-112.

    LI W, XU W. Progress of Traditional Chinese Medicine in the Treatment of Ulcerative Colitis[J]. Journal of Jinzhou Medical University, 2022, 43(2): 108-112.
    [11]
    代汝伟, 高志远, 刘秀丽, 等. 加味白头翁汤治疗热毒炽盛型溃疡性结肠炎的疗效[J]. 西北药学杂志, 2022, 37(4): 157-161.

    DAI R W, GAO Z Y, LIU X L, et al. Therapeutic efficacy of adding flavored Baotouweng Tang in the treatment of heat-toxin blazing type ulcerative colitis[J]. Northwest Pharmaceutical Journal, 2022, 37(4): 157-161.
    [12]
    李嫣红, 吴东升, 芦易, 等. 芍药汤及其加减方治疗溃疡性结肠炎的研究进展[J]. 中国实验方剂学杂志, 2023, 29(9): 37-45.

    LI Y H, WU D S, LU Y, et al. Shaoyaotang and Its Modified Formulas in Treatment of Ulcerative Colitis: A Review[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2023, 29(9): 37-45.
    [13]
    李姿慧, 蔡荣林, 孙娟, 等. 参苓白术散对溃疡性结肠炎脾虚湿困证大鼠结肠组织TLR2、MyD88、COX-2表达的影响[J]. 北京中医药大学学报, 2021, 44(1): 45-53.

    LI Z H, CAI R L, SUN J, et al. Effect of Shenlin Baizhu San on expressions of TLR2, MyD88, COX-2 in ulcerative colitis rats with spleen deficiency and dampness stagnation pat-tern[J]. Journal of Beijing University of Traditional Chinese Medicine, 2021, 44(1): 45-53.
    [14]
    曾武淼, 文娟娟. 自拟柔肝醒脾汤加味治疗溃疡性结肠炎的疗效及对肠道菌群、血清IL-4、IL-17水平的影响[J]. 四川中医, 2022, 40(5): 117-120.

    ZENG W M, WEN J J. Efficacy of self-proposed soft liver and spleen awakening soup with added flavor in the treatment of ulcerative colitis and its effect on intestinal flora and serum IL-4 and IL-17 levels[J]. Sichuan Traditional Chinese Medicine, 2022, 40(5): 117-120.
    [15]
    邵启蕙, 郭颂铭, 董秋安. 自拟"溃结2号方"治疗溃疡性结肠炎的临床观察[J]. 同济大学学报(医学版), 2020, 41(1): 112-116.

    SHAO Q H, GUO S M, DONG Q A. Efficacy of Kuijie No. 2 prescription for patients with ulcerative colitis[J]. Journal of Tongji University (Medical Science), 2020, 41(1): 112-116.
    [16]
    傅智浩, 韩啸, 石磊, 等. 《中成药治疗溃疡性结肠炎临床应用指南》解读[J]. 中国中西医结合消化杂志, 2023, 31(9): 659-664.

    FU Z H, HAN X, SHI L, et al. Interpretation on the Clinical Application Guidelines on Chinese Patent Medicine in the Treatment for Ulcerative Colitis[J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2023, 31(9): 659-664.
    [17]
    林崖, 杨维忠, 王秋雁, 等. 虎地肠溶胶囊联合美沙拉嗪治疗溃疡性结肠炎的临床研究[J]. 现代药物与临床, 2019, 34(9): 2778-2781.

    LIN Y, YANG W Z, WANG Q Y, et al. Clinical study on Hudi Enteric-coated Capsules combined with mesalazine in treatment of ulcerative colitis[J]. Drugs & Clinic, 2019, 34(9): 2778-2781.
    [18]
    潘智, 邵赛丹, 黄登, 等. 虎地肠溶胶囊联合奥沙拉秦对慢性溃疡性结肠炎患者肠黏膜病变、血清炎性因子及NGAL和MMP-9表达影响[J]. 浙江医学, 2021, 43(21): 2337-2340.

    PAN Z, SHAO S D, HUANG D, et al. Effect of Hudi enteric coated capsule combined with olsalazine on intestinal mucosal lesions, inflammatory factors and expression of NGAL and MMP-9 in patients with chronic ulcerative colitis[J]. Zhejiang Medical Journal, 2021, 43(21): 2337-2340.
    [19]
    邢潇潇, 郭建波, 李华山. 补脾益肠丸治疗溃疡性结肠炎的系统评价与Meta分析[J]. 海南医学院学报, 2022, 28(1): 41-47, 57.

    XING X X, GUO J B, LI H S. Systematic review and meta-analysis of Bupi Yichang pills for ulcerative colitis[J]. Journal of Hainan Medical University, 2022, 28(1): 41-47, 57.
    [20]
    肖秋萍, 赵畅, 刘端勇, 等. 补脾益肠丸重塑CD4~+T细胞亚群稳态缓解溃疡性结肠炎的机制研究[J]. 天津医药, 2023, 51(12): 1332-1338.

    XIAO Q P, ZHAO C, LIU D Y, et al. Study on mechanism of Bupi Yichang pill in alleviating experimental ulcerative colitis by restoring the homeostasis of CD4+T cell subpopulations[J]. Tianjin Medical Journal, 2023, 51(12): 1332-1338.
    [21]
    江海燕, 王新月, 王建云, 等. 解毒活血灌肠方联合中药口服治疗溃疡性结肠炎患者的临床研究[J]. 中华全科医学, 2021, 19(11): 1925-1928, 1955. doi: 10.16766/j.cnki.issn.1674-4152.002202

    JIANG H Y, WANG X Y, WANG J Y, et al. Clinical study of Jiedu Huoxue Decoction enema combined with oral Chinese medicine in patients with ulcerative colitis[J]. Chinese Journal of General Practice, 2021, 19(11): 1925-1928, 1955. doi: 10.16766/j.cnki.issn.1674-4152.002202
    [22]
    DAI X L, ZHANG A M, LIN H, et al. Qingchang suppositry induced remission in patients with mild-to-moderate ulcerative proctitis: a multicenter, prospective, randomized, parallel-controlled clinical trial[J]. J Tradit Chin Med, 2024, 44(1): 156-162.
    [23]
    景姗, 刘小丽, 徐逸, 等. 溃疡性结肠炎与抑郁的相关因素分析及中医情志治疗方法探讨[J]. 光明中医, 2021, 36(13): 2093-2096.

    JING S, LIU X L, XU Y, et al. Analysis of the Correlation Factors between Ulcerative Colitis and Depression and Discussion on the Treatment of Emotion in Traditional Chinese medicine[J]. Guangming Journal of Chinese Medicine, 2021, 36(13): 2093-2096.
    [24]
    许宝才, 陈伟. 雷氏银盏隔姜灸联合补火生土法干预缓解期溃疡性结肠炎的效果评价[J]. 中华全科医学, 2022, 20(5): 844-847, 902. doi: 10.16766/j.cnki.issn.1674-4152.002469

    XU B C, CHEN W. Evaluation of the effect of LEI's Yinzhan ginger moxibustion combined with Buhuo Shengtu therapy on ulcerative colitis in the remission stage[J]. Chinese Journal of General Practice, 2022, 20(5): 844-847, 902. doi: 10.16766/j.cnki.issn.1674-4152.002469
    [25]
    伍晓涵, 刘占举. 溃疡性结肠炎最新发病机制的认识[J]. 中国中西医结合消化杂志, 2023, 31(4): 237-242.

    WU X H, LIU Z J. Recent advances in the pathogenesis of ulcerative colitis[J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2023, 31(4): 237-242.
    [26]
    唐志鹏, 郝微微. 溃疡性结肠炎的中西医结合治疗[M]. 北京: 科学出版社, 2021: 7.

    TANG Z P, HAO W W. Combined Chinese and Western medicine treatment of ulcerative colitis[M]. Beijing: Science Press, 2021: 7.
    [27]
    MENTELLA M C, SCALDAFERRI F, PIZZOFERRATO M, et al. Nutrition, IBD and gut microbiota: a review[J]. Nutrients, 2020, 12(4): 944.
    [28]
    GRAHAM D B, XAVIER R J. Pathway paradigms revealed from the genetics of inflammatory bowel disease[J]. Nature, 2020, 578(7796): 527-539.
    [29]
    LI Q, ZHENG S, NIU K, et al. Paeoniflorin improves ulcerative colitis via regulation of PI3K AKT based on network pharmacology analysis[J]. Exp Ther Med, 2024, 27(4): 125.
    [30]
    HERRADOR L M, MARTÍN M R, NAVAS L V M. Dietary interventions in ulcerative colitis: a systematic review of the evidence with meta-analysis[J]. Nutrients, 2023, 15(19): 4194. DOI: 10.3390/nu15194194.
    [31]
    TOSI M, MONTANARI C, BONA F, et al. Dietary inflammatory potential in pediatric diseases: a narrative review[J]. Nutrients, 2023, 15(24): 5095. DOI: 10.3390/nu15245095.
    [32]
    GREIF V, SCHULZ-KUHNT A, WEGHORN J, et al. Mo1880–ulcerative colitis patients are characterized by a decreased frequency of systemic Gpr15+ innate lymphoid cells[J]. Gastroenterology, 2019, 156(6): S-873. DOI: 10.1016/S0016-5085(19)39147-4.
    [33]
    叶佳, 朱梅萍, 刘畅. 溃疡性结肠炎患者肠道菌群紊乱与Th17/Treg平衡及相关细胞因子的关系[J]. 中国医药导报, 2021, 18(16): 86-90.

    YE J, ZHU M P, LIU C. Relationship between intestinal flora disorder and Th17/Treg balance and related cytokines in patients with ulcerative colitis[J]. China Mediceal Herald, 2021, 18(16): 86-90.
    [34]
    宋亚芳, 裴丽霞, 赵婷婷, 等. 溃疡性结肠炎免疫因素发病机制的研究进展[J]. 医学研究生学报, 2019, 32(4): 432-436.

    SONG Y F, PEI L X, ZHAO T T, et al. Research progress on the pathogenesis of immune factors in ulcerative colitis[J]. Journal of Medical Postgraduates, 2019, 32(4): 432-436.
    [35]
    崔爱丽, 庞世超, 于莹莹. 溃疡性结肠炎患者肠道菌群及体液免疫变化的临床意义[J]. 中国肛肠病杂志, 2021, 41(4): 28-30.

    Cui A L, PANG S C, YU Y Y. Clinical Significance of Intestinal Flora and Humoral Immunity Change of UC Patients[J]. Chinese Journal of Coloproctology, 2021, 41(4): 28-30.
    [36]
    GERSHON M D. The thoughtful bowel[J]. Acta physiologica (Oxford, England), 2020, 228(1): e13331. DOI: 10.1111/apha.13331.
    [37]
    MORYS J M, KACZÓWKA A, JEZEWSKA M. Assessment of selected psychological factors in patients with inflammatory bowel disease[J]. Prz Gastroenterol, 2016, 11(1): 47-53.
    [38]
    匡琪, 王爱祥, 向瑶. 心理因素、肠道菌群、环境与溃疡性结肠炎发病的关系分析[J]. 中国卫生统计, 2021, 38(5): 742-745, 749.

    KUANG Q, WANG A X, XIANG Y. Analysis of the relationship between psychological factors, intestinal flora, environment and the development of ulcerative colitis[J]. Chinese Journal of Health Statistics, 2021, 38(5): 742-745, 749.
    [39]
    RUBIN D T, ANANTHAKRISHNAN A N, SIEGEL C A, et al. ACG Clinical Guideline: ulcerative colitis in adults[J]. Am J Gastroenterol, 2019, 114(3): 384-413.
    [40]
    SINGH A, MAHAJAN R, KEDIA S, et al. Use of thiopurines in inflammatory bowel disease: an update[J]. Intest Res, 2022, 20(1): 11-30.
    [41]
    许馨文, 周群燕, 陈中霞, 等. 生物制剂治疗中重度溃疡性结肠炎的研究进展[J]. 胃肠病学, 2021, 26(6): 363-367.

    XU X W, ZHOU Q Y, CHEN Z X, et al. Advances in Study on Biological Agents in Treatment of Moderate-to-severe Ulcerative Colitis[J]. Chinese Journal of Gastroenterology, 2021, 26(6): 363-367.
    [42]
    陈岩勤, 李玉桂, 杨盛刚, 等. 微生态制剂对小鼠溃疡性结肠炎的作用[J]. 中国老年学杂志, 2021, 41(5): 1037-1041.

    CHEN Y Q, LI Y G, YANG S, et al. Effect of probiotics on ulcerative colitis of mice[J]. Chinese Journal of Gerontology, 2021, 41(5): 1037-1041.
    [43]
    徐金兰, 黄绦璧, 袁浩, 等. 粪便微生物移植在溃疡性结肠炎治疗中的研究进展[J]. 医学综述, 2021, 27(12): 2384-2390.

    XU J L, HUANG T B, YUAN H, et al. Research Progress of Fecal Microbial Transplantation in Treatment of Ulcerative Colitis[J]. Medical Recapitulate, 2021, 27(12): 2384-2390.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (46) PDF downloads(2) Cited by()
    Proportional views
    Related

    Address：No. 287, Changhuai Road, Bengbu, Anhui Province, 233004, P.R.ChinaphoneNo：0552-3066635； 0552-3051890Email：zhqkyx@163.com

    Copyright © Chinese Journal of General Practice皖ICP备2020018345号-2

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return